Form 8-K - Current report:
SEC Accession No. 0001829126-26-001472
Filing Date
2026-02-19
Accepted
2026-02-19 15:13:51
Documents
14
Period of Report
2026-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blackhawkacq_8k.htm   iXBRL 8-K 38575
2 EXHIBIT 10.1 blackhawkacq_ex10-1.htm EX-10.1 38128
  Complete submission text file 0001829126-26-001472.txt   305141

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bkhau-20260219.xsd EX-101.SCH 4063
4 XBRL DEFINITION FILE bkhau-20260219_def.xml EX-101.DEF 27156
5 XBRL LABEL FILE bkhau-20260219_lab.xml EX-101.LAB 37607
6 XBRL PRESENTATION FILE bkhau-20260219_pre.xml EX-101.PRE 25776
16 EXTRACTED XBRL INSTANCE DOCUMENT blackhawkacq_8k_htm.xml XML 6727
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 001-41984 | Film No.: 26653887
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)